Arcutis reups with $225M ahead of critical year
To view this email as a web page, click here

Today's Rundown

Featured Story

Oravax inks oral COVID-19 vaccine supply deal amid talks about public listing

Oravax Medical has taken an early step toward the commercialization of its oral COVID-19 vaccine by entering into a deal to ship 10 million doses of the clinical-phase candidate to Southeast Asia.

read more

Top Stories

EyeD lands $51M to take glaucoma implant into the clinic

EyeD Pharma’s new spin on an old molecule has attracted investor support, giving it 45 million euros ($51 million) to advance an implant that could challenge AbbVie for the glaucoma market.

read more

Arcutis reups ahead of critical year for topical drug delivery tech, securing $225M debt financing to fund product launch, pivotal readouts

Arcutis Biotherapeutics has topped up its bank balance ahead of a critical year. With 2022 bringing a trio of pivotal clinical trial readouts and potentially a FDA approval, the topical drug delivery specialist has turned to SLR Capital Partners for a $225 million loan facility.

read more

SanPlena sets out to show wearable patches are the key to faster weight loss

Can wearable drug delivery patches enable obese patients to lose 15% of their body weight in as little as two months? That is the question EOFlow and Zihipp are aiming to answer by creating joint venture SanPlena

read more

2021 drug approvals: In a year dominated by COVID, biopharma managed to deliver 55 new drugs

Each year, many scientists and other experts working in the biopharma industry see years of their work culminate in FDA approvals. With the COVID-19 crisis stretching into its third year, the 2021 batch of new drug approvals clearly demonstrates that the sector has learned how to operate in a pandemic.

read more

Resources

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Whitepaper: Modernizing Key Clinical Trial Processes with Artificial Intelligence

This whitepaper addresses where AI can make the biggest impact in clinical trials. The stakes are too high for patients to leave decision-making to machines, but AI can lend administrative support that empowers staff and medical experts alike to carry out their jobs more effectively.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events